{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:14:16Z","timestamp":1788988456894,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cca.2021.10.015","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T13:59:19Z","timestamp":1634565559000},"page":"339-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis"],"prefix":"10.1016","volume":"523","author":[{"given":"Pooja","family":"Basthi Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar Prasad","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-7493","authenticated-orcid":false,"given":"Dharshan","family":"Rangaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Musunuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Prabhu Attur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0707-3459","authenticated-orcid":false,"given":"Ganesh","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shailesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2021.10.015_b0005","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1038\/s41598-018-26226-6","article-title":"Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis","volume":"8","author":"Lei","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2021.10.015_b0010","first-page":"94","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis, Lancet","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3350\/cmh.2014.20.2.185","article-title":"Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal","volume":"20","author":"Choi","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0020","first-page":"554","article-title":"Prevalence of Acute Kidney Injury in Patients with Liver Cirrhosis","volume":"58","author":"Thapa","year":"2020","journal-title":"JNMA J. Nepal Med. Assoc."},{"key":"10.1016\/j.cca.2021.10.015_b0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/gastro\/gox009","article-title":"Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome","volume":"5","author":"Bucsics","year":"2017","journal-title":"Gastroenterol. Rep."},{"key":"10.1016\/j.cca.2021.10.015_b0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"TRIBE-AKI Consortium, Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.cca.2021.10.015_b0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0040","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1515\/cclm-2016-0973","article-title":"Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption","volume":"55","author":"Kashani","year":"2017","journal-title":"Clin. Chem. Lab. Med. CCLM."},{"key":"10.1016\/j.cca.2021.10.015_b0045","first-page":"1550","article-title":"Acute kidney injury in patients with cirrhosis: perils and promise","volume":"11","author":"Belcher","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.cca.2021.10.015_b0050","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1038\/s41598-019-51053-8","article-title":"Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis","volume":"9","author":"Jo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2021.10.015_b0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","article-title":"Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis","volume":"16","author":"Velez","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2021.10.015_b0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0065","first-page":"15","article-title":"Neutrophil Gelatinase Associated Lipocalin (NGAL) \u2013 a biomarker of renal dysfunction in patients with liver cirrhosis: Do we have enough proof?","volume":"8","author":"Firu","year":"2015","journal-title":"J. Med. Life."},{"key":"10.1016\/j.cca.2021.10.015_b0070","first-page":"45","article-title":"Beyond Early Diagnosis: Prognostic Biomarkers for Monitoring Acute Kidney Injury, Hong Kong","volume":"12","author":"Liang","year":"2010","journal-title":"J. Nephrol."},{"key":"10.1016\/j.cca.2021.10.015_b0075","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cca.2021.10.015_b0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00365510802150158","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease","volume":"241","author":"Devarajan","year":"2008","journal-title":"Scand. J. Clin. Lab. Investig. Suppl."},{"key":"10.1016\/j.cca.2021.10.015_b0085","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1681\/ASN.2016101127","article-title":"Perspective on Clinical Application of Biomarkers in AKI","volume":"28","author":"Parikh","year":"2017","journal-title":"J. Am. Soc. Nephrol. JASN."},{"key":"10.1016\/j.cca.2021.10.015_b0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.cca.2021.10.015_b0095","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.cca.2021.10.015_b0100","first-page":"248","article-title":"Acute kidney injury in patients with cirrhosis of liver: Clinical profile and predictors of outcome, Indian","volume":"37","author":"Shetty","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0105","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.3748\/wjg.v25.i28.3684","article-title":"Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?","volume":"25","author":"Chancharoenthana","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0110","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0115","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.16084","article-title":"A Review of Hepatorenal Syndrome","author":"Subedi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.cca.2021.10.015_b0120","article-title":"Current knowledge about biomarkers of acute kidney injury in liver cirrhosis","author":"Lee","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0035-1564794","article-title":"Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options","volume":"32","author":"Erly","year":"2015","journal-title":"Semin. Interv. Radiol."},{"key":"10.1016\/j.cca.2021.10.015_b0130","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/liv.13893","article-title":"Hepatorenal syndrome in the era of acute kidney injury","volume":"38","author":"Sol\u00e9","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.cca.2021.10.015_b0135","unstructured":"A. Dominguez, V. Muppidi, S. Gupta, Hyperaldosteronism, in: StatPearls, StatPearls Publishing, Treasure Island (FL), 2021. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499983\/ (accessed September 28, 2021)."},{"key":"10.1016\/j.cca.2021.10.015_b0140","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ."},{"key":"10.1016\/j.cca.2021.10.015_b0145","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis, J. Hepatol. 53 (2010) 397\u2013417. 10.1016\/j.jhep.2010.05.004.","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"10.1016\/j.cca.2021.10.015_b0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal Syndrome","volume":"14","author":"Francoz","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN."},{"key":"10.1016\/j.cca.2021.10.015_b0155","doi-asserted-by":"crossref","unstructured":"Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis | Nephrology Dialysis Transplantation | Oxford Academic, (n.d.). https:\/\/academic.oup.com\/ndt\/article\/27\/7\/2625\/1849191 (accessed June 3, 2021).","DOI":"10.1093\/ndt\/gfs067"},{"key":"10.1016\/j.cca.2021.10.015_b0160","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4254\/wjh.v7.i7.993","article-title":"Acute kidney injury in patients with chronic liver disease","volume":"7","author":"Rognant","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0165","first-page":"159","article-title":"[Renal damage in liver cirrhosis: pathophysiology and management], Nihon Rinsho Jpn","volume":"52","author":"Yamamoto","year":"1994","journal-title":"J Clin. Med."},{"key":"10.1016\/j.cca.2021.10.015_b0170","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.3748\/wjg.v13.i42.5552","article-title":"Acute renal dysfunction in liver diseases","volume":"13","author":"Betrosian","year":"2007","journal-title":"World J. Gastroenterol. WJG."},{"key":"10.1016\/j.cca.2021.10.015_b0175","unstructured":"C.K. Ng, M.H. Chan, M.H. Tai, C.W. Lam, Hepatorenal Syndrome, Clin. Biochem. Rev. 28 (2007) 11. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1904420\/ (accessed June 16, 2021)."},{"key":"10.1016\/j.cca.2021.10.015_b0180","first-page":"457","article-title":"Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study, Indian","volume":"39","author":"Kumar","year":"2020","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0185","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-137-9-200211050-00010","article-title":"Diagnosis and Treatment of Acute Tubular Necrosis","volume":"137","author":"Esson","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2021.10.015_b0190","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","article-title":"Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome","volume":"46","author":"Krag","year":"2007","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.cca.2021.10.015_b0195","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical Application of Kidney Biomarkers in Cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"10.1016\/j.cca.2021.10.015_b0200","doi-asserted-by":"crossref","DOI":"10.1007\/s00431-021-04076-1","article-title":"Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis","author":"Vijay","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cca.2021.10.015_b0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/gut.50.1.106","article-title":"Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver","volume":"50","author":"Gerbes","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cca.2021.10.015_b0210","first-page":"301","article-title":"Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis, Korean","volume":"16","author":"Chung","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0215","first-page":"360","article-title":"[Diagnostic value of serum cystatin C for acute kidney injury in patients with liver cirrhosis], Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi Chin","volume":"25","author":"Cai","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.cca.2021.10.015_b0225","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jgh.14387","article-title":"Korean Study Group of Portal Hypertension, Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-\u03b2-D-glucosaminidase","volume":"34","author":"Kim","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0230","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s11255-020-02530-x","article-title":"Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures","volume":"52","author":"Zdziechowska","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cca.2021.10.015_b0235","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney Biomarkers and Differential Diagnosis of Patients With Cirrhosis and Acute Kidney Injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.cca.2021.10.015_b0240","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary Biomarkers and Progression of AKI in Patients with Cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN."},{"key":"10.1016\/j.cca.2021.10.015_b0245","first-page":"398","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis, Liver Int","volume":"33","author":"Shah","year":"2013","journal-title":"Off. J. Int. Assoc. Study Liver."},{"key":"10.1016\/j.cca.2021.10.015_b0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/0886022X.2019.1578234","article-title":"Kidney injury molecule-1 expression predicts structural damage and outcome in histological acute tubular injury","volume":"41","author":"Cai","year":"2019","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cca.2021.10.015_b0255","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v24.i21.2300","article-title":"Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis","volume":"24","author":"Jiang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0260","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOG.0000000000000168","article-title":"Renal dysfunction in cirrhosis","volume":"31","author":"Urrunaga","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1440-1746.2012.07288.x","article-title":"Acute renal failure in cirrhotic patients with severe sepsis: value of urinary interleukin-18","volume":"28","author":"Tsai","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0270","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/376795","article-title":"Urinary biomarkers of acute kidney injury in patients with liver cirrhosis","volume":"2014","author":"Qasem","year":"2014","journal-title":"ISRN Nephrol."},{"key":"10.1016\/j.cca.2021.10.015_b0275","first-page":"2867241","article-title":"Evaluation of the Biomarkers HMGB1 and IL-6 as Predictors of Mortality in Cirrhotic Patients with Acute Kidney Injury","author":"de Oliveira Gomes","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cca.2021.10.015_b0280","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1590\/s0004-2803.201800000-75","article-title":"Evaluation of the behavior of levels of HMGB1 and IL6 as predictors of infection, acute kidney injury and mortality in cirrhotic patients with variceal bleeding","volume":"55","author":"Vilela","year":"2018","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccc.2019.08.010","article-title":"The Role of Biomarkers in Acute Kidney Injury","volume":"36","author":"Srisawat","year":"2020","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.cca.2021.10.015_b0290","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ki.2009.422","article-title":"Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury","volume":"77","author":"Ferguson","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2021.10.015_b0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3346\/jkms.2013.28.1.100","article-title":"The Role of Urinary Liver-Type Fatty Acid-Binding Protein in Critically Ill Patients","volume":"28","author":"Cho","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cca.2021.10.015_b0300","first-page":"3083","article-title":"Korean Study Group of Portal Hypertension, Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study, Liver Int","volume":"40","author":"Kim","year":"2020","journal-title":"Off. J. Int. Assoc. Study Liver."},{"key":"10.1016\/j.cca.2021.10.015_b0305","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-148-11-200806030-00003","article-title":"Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase-Associated Lipocalin for Diagnosing Acute Kidney Injury","volume":"148","author":"Nickolas","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2021.10.015_b0310","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit. Care Lond. Engl."},{"key":"10.1016\/j.cca.2021.10.015_b0315","first-page":"760","article-title":"[Application value of urinary IGFBP7 and TIMP-2 in acute kidney injury with decompensated hepatitis B virus-related liver cirrhosis], Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi Chin","volume":"28","author":"Han","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0320","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/0886022X.2020.1801468","article-title":"Could KIM-1 and NGAL levels predict acute kidney injury after paracentesis? - preliminary study","volume":"42","author":"Pietrukaniec","year":"2020","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cca.2021.10.015_b0325","first-page":"49","article-title":"Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study, Liver Int","volume":"34","author":"Gungor","year":"2014","journal-title":"Off. J. Int. Assoc. Study Liver."},{"key":"10.1016\/j.cca.2021.10.015_b0330","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/nep.13226","article-title":"Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study","volume":"24","author":"Jaques","year":"2019","journal-title":"Nephrol. Carlton Vic."},{"key":"10.1016\/j.cca.2021.10.015_b0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/sjamf.sjamf_110_19","article-title":"Serum and urinary neutrophil gelatinase-associated lipocalin in chronic liver disease patients and its value in detecting renal impairment","volume":"4","author":"Elshemy","year":"2020","journal-title":"Sci. J. Al-Azhar Med. Fac. Girls."},{"key":"10.1016\/j.cca.2021.10.015_b0340","article-title":"The efficacy of biomarkers in the diagnosis of acute kidney injury secondary to liver cirrhosis","volume":"100","author":"Yang","year":"2021","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.cca.2021.10.015_b0345","first-page":"154","article-title":"Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) - Early Biomarker for Acute Kidney Injury in Critically Ill Patients","volume":"1","author":"Fodor","year":"2015","journal-title":"J. Crit. Care Med. Univ. Med. Si Farm. Din Targu-Mures."},{"key":"10.1016\/j.cca.2021.10.015_b0350","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-015-0372-5","article-title":"Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions","volume":"15","author":"Treeprasertsuk","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0355","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/612032","article-title":"NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury","volume":"2013","author":"Noto","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.cca.2021.10.015_b0360","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1177\/0300060517709199","article-title":"Evaluation of serum neutrophil gelatinase-associated lipocalin in predicting acute kidney injury in critically ill patients","volume":"45","author":"Hang","year":"2017","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.cca.2021.10.015_b0365","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5604\/01.3001.0012.0931","article-title":"Urinary Neutrophil Gelatinase-Associated Lipocalin in Cirrhotic Patients with Acute Kidney Injury","volume":"17","author":"Hamdy","year":"2018","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ekir.2016.04.003","article-title":"Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Distinguishes Sustained From Transient Acute Kidney Injury After General Surgery","volume":"1","author":"Au","year":"2016","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.cca.2021.10.015_b0375","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1517\/17530059.2.4.387","article-title":"Emerging urinary biomarkers in the diagnosis of acute kidney injury","volume":"2","author":"Devarajan","year":"2008","journal-title":"Expert Opin. Med. Diagn."},{"key":"10.1016\/j.cca.2021.10.015_b0380","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.carres.2010.07.024","article-title":"Structural characterization of glycoprotein NGAL, an early predictive biomarker for acute kidney injury","volume":"345","author":"Zhao","year":"2010","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.cca.2021.10.015_b0385","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/apt.12299","article-title":"Predicting the development of acute kidney injury in liver cirrhosis \u2013 an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers","volume":"37","author":"Slack","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2021.10.015_b0390","first-page":"hep.30592","article-title":"Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study","author":"Huelin","year":"2019","journal-title":"Hepatology."},{"key":"10.1016\/j.cca.2021.10.015_b0395","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/ijn.IJN_254_19","article-title":"Utility of Urinary Neutrophil gelatinase associated lipocalin (NGAL) in decompensated cirrhosis","volume":"30","author":"Reddy","year":"2020","journal-title":"Indian J. Nephrol."},{"key":"10.1016\/j.cca.2021.10.015_b0400","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/liv.12232","article-title":"Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study","volume":"34","author":"Gungor","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.cca.2021.10.015_b0405","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cca.2021.10.015_b0410","doi-asserted-by":"crossref","first-page":"e00359","DOI":"10.14309\/ctg.0000000000000359","article-title":"Chung, Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/cc11380","article-title":"Clinical review: Biomarkers of acute kidney injury: where are we now?","volume":"16","author":"Ostermann","year":"2012","journal-title":"Crit. Care Lond. Engl."},{"key":"10.1016\/j.cca.2021.10.015_b0420","first-page":"1003","article-title":"Urine Interleukin 18 and Lipocalin 2 are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-Analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.cca.2021.10.015_b0425","first-page":"970","article-title":"Urinary neutrophil gelatinase-associated lipocalin determines short-term mortality and type of acute kidney injury in cirrhosis, JGH Open Open Access","volume":"4","author":"Udgirkar","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2021.10.015_b0430","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11938-020-00292-0","article-title":"Latest Treatment of Acute Kidney Injury in Cirrhosis","volume":"18","author":"Wong","year":"2020","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"10.1016\/j.cca.2021.10.015_b0435","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J. Hepatol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:04:24Z","timestamp":1757862264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121003594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":87,"alternative-id":["S0009898121003594"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.015","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}